usd $5.4 mill revenues at 55% gross margins = $2.97 mill gross profit ie AFTER manufacturing and operating costs. Take out forecast fixed costs for 2nd quarter (stated in the sept quarterly ann) of USD $2.85 mill and you are left with +ve c/f of $120k. The key point here is whether the management were also being loose with the forecast fixed costs back in the Sept Quarterly announcement. These, one would have thought, would be much easier to control and predict at the time of publishing. It'll be interesting to see come the December quarterly announcement.
- Forums
- ASX - By Stock
- YOW
- Ann: Revenue Guidance Update and CEO Appointment
YOW
yowie group ltd
Add to My Watchlist
0.00%
!
1.4¢

Ann: Revenue Guidance Update and CEO Appointment, page-59
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.211M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
YOW (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online